Monitor the conference presentation for any pipeline updates or strategic commentary that could move the stock. Without access to the presentation content, the filing itself provides no actionable trading signal.
ABEO drugs
ABEO drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 15 $5.47entry
- T+1 · 2mo ago −1.55%α −1.88% · $5.39
- T+5 · 8w ago +1.83%α +1.01% · $5.57
- T+20 · 5w ago −17.37%α −20.34% · $4.52
- T+44 · todayOpen
- T+60 · in 22d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Abeona Therapeutics filed an 8-K furnishing an updated investor presentation for the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The filing is a routine Regulation FD disclosure of a conference presentation with no new material financial data or guidance provided. The presentation content was not available for review, limiting the analysis to the filing's metadata.
Key Facts
- Filed 8-K on September 15, 2026 to furnish an updated investor presentation.
- Presentation to be used at the H.C. Wainwright 28th Annual Global Investment Conference.
- No financial results, guidance, or material corporate events disclosed in the filing text.
- Presentation content (Exhibit 99.1) was not available for analysis.
Financial Impact
No financial data disclosed in the filing.
Risk Factors
- Lack of access to the investor presentation limits visibility into any forward-looking statements or pipeline updates.
- Routine conference presentations rarely contain material new information, limiting near-term catalysts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (ABEO), Batch item 1 | 0001493152-26-042702 |
| Document: 0001493152-26-042702-index-headers.html | 0001493152-26-042702 |
| Document: 0001493152-26-042702-index.html | 0001493152-26-042702 |
| Document: 0001493152-26-042702.txt | 0001493152-26-042702 |
| 8-K Filing (ABEO), Batch item 5 | 0001493152-26-042702 |
Track record
29 reports on ABEO
4 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +15.24% at T+20 after the Sep 29, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $2.59 Now $2.60 +0.39% settles Nov 18
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $2.30 Now $2.60 +13.04% settles Nov 17
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $2.29 to $2.42 Now $2.60 +13.54% ▲ +5.68% +6.04% vs SPY
- Nov 9, 20267d ago Press Release Neutral 5/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
- Nov 9, 20267d ago 8-K Bearish 6/10 Entry $2.54 to $2.46 Now $2.60 −2.36% ▲ +3.35% +2.98% vs SPY
- Nov 9, 20267d ago Press Release Mixed 6/10 Entry $2.54 to $2.46 Now $2.60 +2.36% ▼ −3.35% −2.98% vs SPY
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $4.17 to $2.54 Now $2.60 −37.65% ▼ −39.09% −41.46% vs SPY
- Oct 23, 202624d ago SC 13D Bullish 6/10 Entry $4.40 to $4.31 Now $2.60 −40.91% ▼ −2.05% −2.76% vs SPY
- Sep 29, 20266w ago Insider Cluster Bearish 4/10 Entry $5.25 to $5.01 Now $2.60 +50.48% ▲ +4.57% +4.75% vs SPY
- Sep 18, 20268w ago Press Release Bullish 6/10 Entry $5.57 to $5.67 Now $2.60 −53.32% ▲ +1.80% +0.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers